Skip to main content
. 2011 Feb 18;203(9):1282–1291. doi: 10.1093/infdis/jir012

Table 2.

Proportions of Subjects with Detectable Dengue-specific CD4+ T cell Cytokine Production from Presecondary Infection PBMC for Subclinical and Symptomatic Groups

No. of responders: no. of nonresponders
Cytokine Antigen SubclinicalSamples Symptomatic Samples P (by Fisher's exact test)
TNFα D1 14:3 6:4 .36 (NS)
D2 11:6 10:0 .06
D3 7:10 1:9 .19 (NS)
D4 16:1 8:2 .54 (NS)
IFNγ D1 5:12 1:9 .36 (NS)
D2 8:9 2:8 .23 (NS)
D3 7:10 1:9 .19 (NS)
D4 8:9 0:10 .01
IL-2 D1 4:13 0:10 .26 (NS)
D2 10:7 2:8 .11(NS)
D3 5:12 1:9 .36 (NS)
D4 8:9 0:10 .01

NOTE. NS, not statistically significant difference in proportions.